Clinical Trials Logo
  1. Home
  2. Vitrectomy
  3. NCT01023009
  4. Details
NCT01023009 Clinical Trial

Postoperative Evolution After Small Gauge Vitrectomy Without Eye Occlusion

Vitrectomy Clinical Trial

— Vitrectomy  

Clinical Trial Details — Status: Terminated

Administrative data
NCT number NCT01023009
Other study ID # APEC0006
Secondary ID
Status Terminated
Phase
First received
Last updated
Start date May 2009
Est. completion date May 2010

Study information
Verified date May 2024
Source Asociación para Evitar la Ceguera en México
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

After an uneventfully small gauge vitrectomy we don´t think is necessary to occlude the eye for 24 hours

Recruitment information / eligibility
Status Terminated
Enrollment 50
Est. completion date May 2010
Est. primary completion date December 2009
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: - All patients with uneventful vitrectomy Exclusion Criteria: - Complicated vitrectomy or corneal lesion

Study Design

Related Conditions & MeSH terms

Intervention

Procedure:
• vitrectomy

Locations
Country Name City State
Mexico Asociacion para Evitar la Ceguera en Mexico Mexico

Sponsors (1)
Lead Sponsor Collaborator
Asociación para Evitar la Ceguera en México

Country where clinical trial is conducted

Mexico, 

See also
  Status Clinical Trial Phase
Terminated NCT04409808 - IRIS Alfa Clinical Trial A Monocentric, Academic Clinical Trial Safety Study of a Prototype of a New Vitrectomy Device. N/A
Active, not recruiting NCT04566237 - Objective Measurements of the Opacification of the Lens After Vitrectomy N/A
Completed NCT00532415 - Safety and Efficacy of Vitreous Delineating Agent During Vitrectomy Phase 3
Completed NCT04076072 - Beveled-Tip Versus(vs) Standard-Tip Vitrectomy Probe N/A
Not yet recruiting NCT03633266 - Anti-VEGF Instead of Intraoperative PRP in Proliferative Diabetic Retinopathy N/A
Completed NCT00927628 - Macular Hole Reopening N/A
Not yet recruiting NCT03637283 - Anti-VEGF Instead of Intraoperative Fan-shaped Photocoagulation in BRVO Combined With Vitreous Hemorrhage N/A
Completed NCT01255293 - Comparative Study of 1000 Centistoke Versus 5000 Centistoke Silicone Oil for Repair of Complex Retinal Detachments N/A
Completed NCT00737022 - Macular Appearance After Diabetic Vitrectomy N/A
Completed NCT02644694 - PK Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients Undergoing Vitrectomy Phase 1
Completed NCT03902795 - Functional and Morphological Results of Rhegmatogenous Retinal Detachment Treated With Vitrectomy
Completed NCT01319318 - Observational Study of Ocular Inflammation in Patients Undergoing a Pars Plana Vitrectomy N/A
Not yet recruiting NCT04346095 - Oral Sedation in Vitreoretinal Surgery Phase 4
Completed NCT01159665 - The Purpose of This Study is to Evaluate the Pharmacokinetic Properties of Intravitreal Ocriplasmin Prior to Planned Primary Pars Plana Vitrectomy (PPV) Phase 2
Completed NCT00685490 - Vitrectomy for Branch Retinal Vein Occlusion N/A
Completed NCT05446948 - Observation of the Efficacy of Different Vitrectomy Systems to Treat Proliferative Diabetic Retinopathy N/A
Completed NCT05710458 - Performance Comparison of the 25 Gauge 20,000cpm HYPERVIT Dual Blade vs. 10,000cpm ULTRAVIT Vitrectomy Cutter N/A
Terminated NCT02995746 - Intravitreal Dexamethasone Implant for Persistent Macular Thickening and Edema After Vitrectomy for Epiretinal Membrane N/A
Completed NCT03701542 - The Application of M-charts and Microperimetry for the Assessment of Visual Function in Patients After Vitrectomy Due to the Full Thickness Macular Hole.
Completed NCT00799227 - Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema Phase 2